All In MedTech

FDA Clearance Tracker · K251123

Niti-S Biliary Stent; Niti-S Biliary Slim M Stent

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 20, 2026Latest source record: Dec 29, 2025 (this decision)Source: openFDAMethods & limitations

510(k)

Decided

Dec 29, 2025

Unknown

Time to decision

262 days

Received Apr 11, 2025. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Traditional

Device class

Class II

The decision

FDA number
K251123
Device name
Niti-S Biliary Stent; Niti-S Biliary Slim M Stent
Applicant location
Gyeonggi-Do, KR
Received
Apr 11, 2025
Decided
Dec 29, 2025
Decision
Unknown
Submission type
Traditional

Device type

Device class
Class II
Regulation
21 CFR 876.5010

Every decision under product code FGE

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code FGE. The earliest in FDA's data is K821817, decided Aug 10, 1982.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Taewoong Medical Co., Ltd.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.